Evidence map›Paper›PMID 28814711›Full record

ArticleMedical science monitor basic research2017

Reprogramming Bone Marrow Stem Cells to Functional Endothelial Cells in a Mini Pig Animal Model.

Franziska Schlegel, Marco Appler, Michelle Halling, Francis Edwin Smit, Friedrich-Wilhelm Mohr, Stefan Dhein, Pascal Maria Dohmen

Open access · greenAbstract read
In one paragraph

Article in Medical science monitor basic research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Franziska SchlegelDepartment of Cardiac Surgery, Leipzig Heart Center, University of Leipzig, Leipzig, Germany.
Marco ApplerDepartment of Cardiac Surgery, Heart Center Rostock, University of Rostock, Rostock, Germany.
Michelle HallingDepartment of Cardiac Surgery, Leipzig Heart Center, University of Leipzig, Leipzig, Germany.
Francis Edwin SmitDepartment of Cardiothoracic Surgery, Faculty of Health Science, University of the Free State, Bloemfontein, South Africa.
Friedrich-Wilhelm MohrDepartment of Cardiac Surgery, Leipzig Heart Center, University of Leipzig, Leipzig, Germany.
Stefan DheinDepartment of Cardiac Surgery, Leipzig Heart Center, University of Leipzig, Leipzig, Germany.
Pascal Maria DohmenDepartment of Cardiac Surgery, Leipzig Heart Center, University of Leipzig, Leipzig, Germany.
Leipzig Heart Institute · DEUniversity of the Free State · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The aims of this study were to compare the morphological, biochemical, and functional properties of reprogrammed bone marrow stem cell (BMSC)-derived arterial endothelial cells (AECs) and venous endothelial cells (VECs), following adenosine triphosphate (ATP)-stimulation in a mini pig animal model. MATERIAL AND METHODS Bone marrow aspiration was performed in six adult mini pigs. Harvested mononuclear cells were isolated, cultured, and treated with vascular endothelial growth factor (VEGF) (16 µg/ml). Transformed cells were characterized using immunofluorescence staining for CD31 and von Willebrandt factor (vWF) and expression of endothelial nitric oxide synthase (eNOS). Cell release of nitric oxide (cNO) was measured using spectrophotometry. Matrigel assays were used to investigate angiogenesis in transformed BMSCs. RESULTS Reprogrammed BMSCs in culture showed a typical cobblestone-like pattern of growth. Immunofluorescence staining was positive for CD31 and vWF expression. Expression of eNOS, using immunofluorescence staining and Western blot, showed no difference between the reprogrammed BMSCs and VECs. Spectrophotometric examination following stimulation with 10mmol/l ATP, showed comparable cNO release for reprogrammed BMSCs (10.87±1.76 pmol/106 cells/min) and VECs (13.23±2.16 pmol/10^6 cells/min), but reduced cNO release for AECS (3.44±0.75 pmol/10^6 cells/min). Matrigel assay for angiogenesis showed vascular tube formation of differentiated BMSC endothelial cells (grade 3.25). BMSCs cultured without VEGF did not demonstrate vascular tube formation. CONCLUSIONS The findings of this study showed that eNOS expression and release of NO could be used to show that BMSCs can be reprogrammed to functional VECs and AECs.

Indexed as

Adult Stem CellsAnimalsBone Marrow CellsCell DifferentiationCells, CulturedDisease Models, AnimalEndothelial CellsMesenchymal Stem CellsMesenchymal Stem Cell TransplantationNeovascularization, PathologicNeovascularization, PhysiologicNitric Oxide Synthase Type IIIPlatelet Endothelial Cell Adhesion Molecule-1SwineSwine, MiniatureVascular Endothelial Growth Factor ANitric Oxide Synthase Type IIIPlatelet Endothelial Cell Adhesion Molecule-1Vascular Endothelial Growth Factor Avon Willebrand Factor

Identifiers

PMID28814711
PMCPMC5572781
OpenAlexW2746110682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.